- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 43.83M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $377M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $28M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $14.97M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.19M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $126.63M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $63.01M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $553.12M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $103.79M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $71.9M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $18.3M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $775.45M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $156.55M |
| Operating Income | Q1 2025 · Mar 31, 2025 | $1.75M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$8.05M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$3.32M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $37.66M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $40.17M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.90 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.90 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $7.6M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$9.04M |